ClinicalTrials.Veeva

Menu

Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation (DCalloTX)

T

Technische Universität Dresden

Status

Unknown

Conditions

Graft Versus Host Disease

Treatments

Procedure: blood draw, skin shave biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT00450268
EK208122001

Details and patient eligibility

About

We plan to investigate prospectively and simultaneously skin and blood DC subtypes, their donor/recipient origin and the correlation of DC reconstitution kinetics with treatment, clinical outcome and incidence of aGvHD in patients undergoing allogeneic hematopoietic stem cell transplantation.

Full description

Blood and skin DC reconstitution shall be investigated in patients affected by hematological diseases and receiving HLA-matched, mobilized peripheral blood stem cells from related or unrelated donors. We plan to simultaneously collect and process double biopsies, i.e. from graft versus host disease affected and non-lesional skin of patients at onset of acute graft versus host disease following allogeneic hematopoietic stem cell transplantation. Emigration assay, Chimerism analysis and immunohistochemistry will be performed.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient undergoing an allogeneic hematopoietic stem cell transplantation
  • Older than 18 years
  • WHO-Performance-Status 0 to3
  • Informed consent
  • Graft versus host disease of the skin

Exclusion criteria

  • Clotting parameters more than double of normal
  • Infection of the skin
  • Leucocytes < 1000/µl; Thrombocytes < 20 000/µl

Trial contacts and locations

1

Loading...

Central trial contact

Martin Bornhäuser, Professor; Susanne Gretzinger, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems